IDEXX Laboratories, Inc. (IDXX)

NasdaqGS · Diagnostics & Research

556.13
+10.04 (+1.84%)
Updated Aug 18, 3:13 PM ET
AI Rating
Hold
Overall Score
47
Trend
48
Momentum
29
Risk
69

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

IDEXX Laboratories, Inc. is trading at $556.13, up 1.84% on the session. The 50 day average sits at $561.19 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 43, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $549.98 with resistance near $570.84, so that band frames the current range. Average daily movement is roughly $19.70, or about 3.5% of the share price, which is what any stop placement has to allow for. The overall health score of 47 out of 100 combines a trend score of 48, momentum of 29 and a risk score of 69.

Technical indicators

RSI (14)
43.0
weak
MACD
3.795
bearish crossover
SMA 20
567.33
SMA 50
561.19
SMA 200
--
unknown
ATR (14)
19.70
avg daily range
Support
549.98
Resistance
570.84
Volume vs 20d
0.86x
below average
Volatility
28.0%
annualised
1 month
-4.36%
3 months
+3.40%

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.